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1. Introduction 2. Materials and methods 
Rabbit neutrophils metabolize exogenous arach- 
idonic acid to potent, biologically active compounds, 
the leukotrienes [ 11. Previous work has shown that 
arachidonic acid stimulates neutrophil functions such 
as the release of lysosomal enzymes [2], concomitant 
with its metabolism [3]. A number of inhibitors of 
arachidonic acid metabolism, such as nordihydro- 
guaiaretic acid and eicosatetraynoic acid, inhibit these 
responses even when induced by chemotactic factors 
rather than by aracbidonic acid [2]. Other inhibitors 
of neutrophil response such as quercetin and cyto- 
cholasin A have been found to inhibit the metabolism 
of exogenous arachidonic acid [4]. In order to deter- 
mine whether these inhibitors act directly on the 
metabolism of arachidonic acid or on its uptake from 
the medium, we have investigated the mechanism of 
entry of arachidonic acid into the cell. An energy- 
independent component of this uptake was identified 
using 2-deoxyglucose and antimycin A. This compo- 
nent of uptake appeared to be mediated by a carrier 
with specificity for unsaturated fatty acids and a 
‘Km’ for arachidonic acid between lo6 and lo-’ M. 
Inhibitors of arachidonic acid metabolism in neutro- 
phils did not significantly inhibit its uptake, with the 
exception of the structural analog eicosatetraynoic 
acid. 
Throughout these studies rabbit peritoneal neutro- 
phils were obtained and treated as in [3]. The cells 
were resuspended in complete Hank’s balanced salt 
solution supplemented with dextrose (1 mg/ml). 
Extracellular lactic dehydrogenase, assayed by stan- 
dard procedures was <5% throughout the experi- 
ments reported, demonstrating integrity of the PMNs. 
Abbreviations: PMN, polymorphonuclear leukocyte; NDGA, 
nordihydroguaiaretic acid; BPB, bromophenacyl bromide; 
CYTA, cytochalasin A; CYTB, cytochalasin B; TPCK, L-l- 
tosylamide-2-phenylethyl chloromethyl ketone; INDO, 
indomethacm; QUER, quercetin 
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[ 1 -r4C] Arachidonic acid (55 Ci/mol, Amersham, 
St Louis MO) pre-purified by a silicic acid chromatog 
raphy was added to 2 X 10’ cells/ml at 37°C at the 
indicated concentrations for the indicated times. 
Uptake was terminated by dilution of an 0.1 ml 
aliquot with 1 .O ml of 5% bovine serum albumin 
(Sigma) at 4°C followed by centrifugation at 4°C in 
a Brinkman Model 3200 centrifuge. Pellets obtained 
from centrifugation were either dissolved in 0.2 ml 
10% SDS for measurement of the total radioactivity 
or extracted with 4.0 ml chloroform:methanol(2:1) 
plus 1 .O ml 1 M KC1 to analyze radioactive lipid com- 
ponents. Phospholipids were resolved by thin-layer 
chromatography on LHP-K plates (Whatman, Clifton 
NJ) in chloroform:ethanol:triethylamine:water 
(30:34:35 :8) [5]. Arachidonic acid and its metabolites 
were resolved on silica gel G plates (Analtech) in 
ether:petroleum ether:acetic acid (100:50:1) [61. 
Appropriate standards were visualized with 1% iodine 
spray. Radioactivity was monitored by autoradiography 
on XR-1 Xomat film (Kodak, Rochester NY). Radio- 
activity of labeled lipid components was measured by 
liquid scintillation counting of scraped TLC bands in 
Liquiscint (National Diagnostics, Rochester NY) con- 
taining 10% water and 5% methanol. 
Stock solutions of eicosatetraynoic-, arachidonic-, 
linolenic-, linoleic-, lignoeric-, stearic-, dihomoy- 
linolenic-, eicosatrienoic- and decosatetranoicacids 
@U-Check, Elysian MN) were made up to 0.1 M in 
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dimethylsulfoxide and stored under nitrogen at -70°C. 
Stock solutions of bromophenacylbromide, indo- 
methacin, Ll-tosylamide-2-phenylethyl-chloromethyl 
ketone (TPCK), nordihydroguaiaretic acid and ricin- 
oleic acid, (Sigma Chemical Co., St Louis MO) were 
made up to 0.1 M in ethanol and stored under nitrogen 
at -20°C. All other reagents were analytical grade. 
3. Results and discussion 
Arachidonic acid uptake by rabbit polymorpho- 
nuclear leukocytes was initially measured by incuba- 
tion of cells at 37°C with 3.3 X lose’ M [r4C]arach- 
idonic acid, a level shown to stimulate lysosomal 
enzyme secretion in the presence of cytochalasin B 
[2]. Investigations of fatty acid uptake by mammalian 
cells had normally been done in the presence of 
albumin [lo] which mimics the physiological situation 
for free fatty acids in serum. However, the binding of 
arachidonic acid to albumin complicates uptake anal- 
ysis by presenting an additional variable. Moreover, 
studies on arachidonic acid metabolism by and stimu- 
lation of neutrophils by this group and others have 
been done in the absence of albumin. Therefore, in 
this study albumin was not present during the uptake 
period. Rather albumin was employed to complex 
free arachidonate during the cold centrifugation used 
to terminate the rapid uptake process. 
When the time-dependence of this uptake was 
studied, [ 14C]arachidonic acid was seen to become 
rapidly cell associated with a corresponding loss of 
label from the medium. Lines A and B of fig.1 represent 
data from 2 different rabbits and exemplify the varia- 
tion found in the uptake of arachidonic acid among 
24 individual rabbits tested. (Standard deviation of 
extent of uptake = + 15%.) 
Arachidonic acid taken into a cell becomes rapidly 
esterified into glycerolipids and is also converted into 
oxygenated metabolites. To characterize the uptake 
of arachidonic acid it was necessary to distinguish 
between uptake and metabolism. Since the incorpora- 
tion of fatty acids into glycerolipids requires ATP for 
their conversion to coenzyme A thioesters, an attempt 
was made to uncouple uptake from esterification by 
treating neutrophils with inhibitors of energy metab- 
olism, 2-deoxyglucose plus antimycin A. Fig.2 shows 
that the association of [r4C]arachidonic acid with 
neutrophils thus treated occurred at a slower rate than 
seen in untreated cells. The association of label with 





Fig.1. Rapid association of arachidonic acid with rabbit neutrophik. PMNs were incubated for the indicated times as in section 2: 
(A,B) results (means of duplicate determinations) obtained with PMNs from 2 different rabbits; (-) cell-associated radioactiv- 
ity; (---) media radioactivity. 
294 




















I 2 (Xl061 
I/[204 
Fig.2. Uptake of arachidonic acid in the presence of 2deoxy- 
glucose plus antimycin A. PMNs were incubated with 2 mM 
2deoxyghrcose plus 15 mM antimycin A (---) or dextrose 
(1 mg/ml) (-) at 37°C for 30 min prior to the addition of 
[“Clarachidonic acid. Means of duplicate determinations. 
Fig.3. Concentration dependence of arachidonic acid uptake. 
PMNs were pretreated with antimycin A and 2deoxyghrcose 
described in fig.2 and incubated with the indicative concen- 
tration of arachidonic acid for 15 s. The apparent -l/K, 
for thedatashown is -0.17 X lo6 M-’ (Km =5.9 X 1O-6 M). 
Points shown are the means of 3 expt. 
Table 1 
Distribution of [ Wlarachidonic acid among PMN lipids 
Treatment cpm (% total cpm): [W]Arachidonic acid in 
Arachidonic Hydroxy- 
acid fatty acids 
Phospholipids Triglycerides 
None 21 200 7400 48 900 23 500 
(21.0) (7.3) (48.4) (23.3) 
2DG + ANTA 44 000 7100 15 600 6400 
(60.2) (9.7) (21.3) (8.8) 
Distribution of [Wlarachidonic acid among lipid classes after 15 s of uptake was 
determined on cells pretreated as in fig.2 
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COMPETING FATTY ACID 
Fig.4. Inhibition of the uptake of arachidonic acid by analogs 
and inhibitors of PMN function. Uptake of 10e6 M [r4C]- 
arachidonic acid was measured at 15 s in the presence of 
10-r M of the indicated unlabelled fatty acid. Each bar 
represents the mean of 3 expt. Insert: PMNs were preincu- 
bated for 5 min in the presence of 2 x 10e5 M of the indi- 
cated inhibitor prior to the determination of [ “C]arachidonic 
acid uptake. 
cells increased linearly for >l min. Neither inhibitor 
alone inhibited uptake by >30% (not shown). 
The distribution of radioactivity in lipid extracts 
from such cells was investigated to determine if 
inhibition of esteritication was, in fact, responsible 
for the reduced labeling. The results presented in 
table 1 show that in cells treated with deoxyglucose 
plus antimycin A, 70% of the radioactivity remained 
non-esterified, as opposed to only 28% in untreated 
cells. These results demonstrate that the radioactivity 
which becomes associated with the treated cells can 
provide a reasonable estimate of the initial velocity of 
uptake of arachidonic acid by rabbit neutrophils. 
The dependence of the initial velocity of this 
energy-independent component of uptake on concen- 
tration of arachidonic acid was studied. Results with 
neutrophils from one rabbit are presented in tig.3. 
The double reciprocal analyses generated a ‘Km’-value 
of 5 9 X 10e6 M for these neutrophils. Values of 1.7, 
3.1,3.4 and 5.4 X 10e6 M were obtained with neutro- 
phils from 4 other rabbits, while cells from one rabbit 
produced a double-reciprocal plot with its intercept 
at the origin. We were not able to demonstrate satura- 
tion of uptake unequivocally however (fig.3, insert) 
as arachidonic acid >lO-’ M led to rapid cell lysis, 
evidenced by an increase in extracellular lactic dehy- 
drogenase. Failure to observe curvilinear kinetics at 
or below the Km does not exclude a carrier mediated 
mechanism of uptake [ 111. A more sensitive test for 
a mediated uptake system is competitive inhibition 
by substrate analogs. The ability of various fatty acids 
to inhibit the uptake of arachidonic acid was there- 
fore studied. All unsaturated fatty acids studied 
effectively inhibited the uptake of exogenous [‘“Cl- 
arachidonic acid (fig.4). Docosatetraenoate, dihomo- 
y-linolenate, and the acetylenic analog eicosatetraynoic 
acid were nearly as potent inhibitors as unlabelled 
arachidonate itself. Eighteen carbon unsaturated fatty 
acids were slightly less potent inhibitors and saturated 
fatty acids were ineffective. The hydroxylated fatty 
acid, ricionoleate, was also a potent inhibitor of arach- 
idonic acid uptake. Extensive kinetic analyses will be 
necessary to prove the competitive nature of this 
analog inhibition but the sensitivity of arachidonic 
acid uptake to a variety of substrate analogs and the 
selectivity for unsaturated over saturated analogs is 
suggestive of a mediated transport event. 
The effects of inhibitors of neutrophil function 
which antagonize exogenous arachidonic acid metab- 
olism were also tested. Of the inhibitors studied, only 
NDGA produced measurable inhibition of uptake and 
inhibition was only 20% (fig.4 inset). At these con- 
centrations, NDGA, quercetin, or cytochalasin A 
inhibited the metabolism of exogenous arachidonic 
acid by >95% [4]. Thus these inhibitors appear to 
directly inhibit metabolism of arachidonic acid by 
lipoxygenases of the neutrophil, and that inhibition 
may be presumed to hold for endogenously released 
as well as exogenously provided, arachidonate. 
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